炎症
Online ISSN : 1884-4006
Print ISSN : 0389-4290
ISSN-L : 0389-4290
慢性関節リウマチ患者における組織活性型鎮痛・抗炎症剤インフリー (インドメタシンファルネシル) の血清中および関節液中濃度の検討
真島 龍興近藤 正一
著者情報
ジャーナル フリー

1997 年 17 巻 3 号 p. 247-250

詳細
抄録
Concentration of Indometacin farnesil (IMF), indomethacin (IND) transformed from IMF in serum and synovial fluid were studied after single oral administration of Infree® capsule in patients with rheumatoid arthritis (RA) . Samples of blood, synovial fluid were taken 3 hours, 6 hours, 9 hours and 12 hours after Infree® administration.
1. The maximam concentration of IMF, IND transformed IMF in serum and synovial fluid were obtained at 9 hours after Infree® administration.
2. The ratio of IND/IMF in synovial fluid is constant and higher level than that of IND/IMF in serum. The ratio of IND/IMF in serum is lowered each sampling hours.
These results suggested that Infree® capsule has a constant analgesic/antiinflammatory effect by a good intra-articular transformation of IMF in inflammatory joints of RA patients.
著者関連情報
© 日本炎症・再生医学会
前の記事 次の記事
feedback
Top